Play all audios:
ABSTRACT Intestinal transplant-associated microangiopathy (i-TAM) is an important complication after allogeneic hematopoietic SCT. From 1997 to 2006, 87 of 886 patients with diarrhea after
transplantation received colonoscopic biopsy. i-TAM, GVHD and CMV colitis were diagnosed histopathologically. The median duration from transplantation to the onset of diarrhea was 32 days
(range: 9–130 days) and that from the onset of diarrhea to biopsy was 12 days (range: 0–74 days). The median maximal amount of diarrhea was 2 l/day (range: 130–5600 ml/day).
Histopathological diagnosis included i-TAM (_n_=80), GVHD (_n_=26), CMV colitis (_n_=17) and nonspecific findings (_n_=2) with overlapping. Among 80 patients with i-TAM, abdominal pain was a
major symptom, and only 11 patients fulfilled the proposed criteria for systemic TAM. Non-relapse mortality (NRM) among patients without resolution of diarrhea was 72% and i-TAM comprised
57% of NRM. NRM was 25% among patients without intensified immunosuppression, but was 52, 79 and 100% among those with intensified immunosuppression before diarrhea, after diarrhea, and
before and after diarrhea, respectively. In conclusion, i-TAM is a major complication presenting massive refractory diarrhea and abdominal pain, which causes NRM. Avoiding intensified
immunosuppression that damages vascular endothelium until the resolution of i-TAM may improve transplant outcome. Access through your institution Buy or subscribe This is a preview of
subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only
$21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout
ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS IDENTIFICATION OF ENDOSCOPIC
FACTORS THAT PREDICT POOR RESPONSES TO STEROIDS IN PATIENTS WITH GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE Article 02 November 2020 ENDOSCOPIC FEATURES AND CLINICAL OUTCOMES OF
CYTOMEGALOVIRUS GASTROENTEROCOLITIS IN IMMUNOCOMPETENT PATIENTS Article Open access 18 March 2021 MULTI-INSTITUTIONAL DEVELOPMENT AND VALIDATION OF A NOVEL HISTOLOGIC GRADING SYSTEM FOR
COLONIC GRAFT-VERSUS-HOST DISEASE Article 01 April 2022 REFERENCES * Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS . Bone marrow transplant-associated thrombotic
microangiopathy: a case series. _Bone Marrow Transplant_ 1995; 15: 247–253. CAS PubMed Google Scholar * Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow
transplantation. _Bone Marrow Transplant_ 1994; 14: 495–504. CAS PubMed Google Scholar * Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L _et al_. Thrombotic
thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). _Br J Haematol_ 2002; 118: 1112–1119. Article
Google Scholar * Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M _et al_. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic
microangiopathy after hematopoietic stem cell transplantation. _Biol Blood Marrow Transplant_ 2005; 11: 571–575. Article Google Scholar * Ruutu T, Barosi G, Benjamin RJ, Clark RE, George
JN, Gratwohl A _et al_. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
_Haematologica_ 2007; 92: 95–100. Article Google Scholar * Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B _et al_. Microangiopathy in patients on cyclosporine prophylaxis who
developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. _Blood_ 1989; 73: 2018–2024. CAS PubMed Google Scholar * George JN, Li X, McMinn JR, Terrell
DR, Vesely SK, Selby GB . Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. _Transfusion_ 2004; 44: 294–304.
Article Google Scholar * Hahn T, Alam AR, Lawrence D, Ford L, Baer MR, Bambach B _et al_. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with
dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion. _Transplantation_ 2004; 78: 1515–1522. Article Google Scholar * Shimoni A,
Yeshurun M, Hardan I, Avigdor A, Ben-Bassat I, Nagler A . Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is
not reduced. _Biol Blood Marrow Transplant_ 2004; 10: 484–493. Article Google Scholar * Kojouri K, George JN . Thrombotic microangiopathy following allogeneic hematopoietic stem cell
transplantation. _Curr Opin Oncol_ 2007; 19: 148–154. Article Google Scholar * Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K _et al_. Risk factor analysis for thrombotic
microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. _Am J Hematol_ 2006; 81: 525–531. Article Google Scholar * Uderzo C, Bonanomi
S, Busca A, Renoldi M, Ferrari P, Iacobelli M _et al_. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
_Transplantation_ 2006; 82: 638–644. Article Google Scholar * Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA _et al_. Transplant-associated microangiopathy in patients
receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. _Biol Blood Marrow Transplant_ 2007; 13: 469–477. Article CAS Google Scholar *
Martinez MT, Bucher C, Stussi G, Heim D, Buser A, Tsakiris DA _et al_. Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants. _Bone
Marrow Transplant_ 2005; 36: 993–1000. Article CAS Google Scholar * Lewis GD, Campbell WB, Johnson AR . Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial
cells. _Endocrinology_ 1986; 119: 62–69. Article CAS Google Scholar * Cox GJ, Matsui SM, Lo RS, Hinds M, Bowden RA, Hackman RC _et al_. Etiology and outcome of diarrhea after marrow
transplantation: a prospective study. _Gastroenterology_ 1994; 107: 1398–1407. Article CAS Google Scholar * Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR _et al_. A
retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. _Blood_ 1990; 76: 1464–1472. CAS PubMed Google Scholar * Deeg HJ . How I treat refractory acute
GVHD. _Blood_ 2007; 109: 4119–4126. Article CAS Google Scholar * Nishida T, Hamaguchi M, Hirabayashi N, Haneda M, Terakura S, Atsuta Y _et al_. Intestinal thrombotic microangiopathy after
allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. _Bone Marrow Transplant_ 2004; 33: 1143–1150. Article CAS Google Scholar * Nadasdy
T, Silva FG . Adult renal disease. In: Sternberg SS (ed). _Diagnostic Surgical Pathology_, 3rd edn, Lippincott Williams & Wilkins: Philadelphia, PA, 1999, pp 1736–1738. Google Scholar
* Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S _et al_. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. _Semin Hematol_
1991; 28: 250–259. CAS Google Scholar * Dee SL, Butt K, Ramaswamy G . Intestinal ischemia. _Arch Pathol Lab Med_ 2002; 126: 1201–1204. PubMed Google Scholar * Couriel DR, Saliba R,
Escalon MP, Hsu Y, Ghosh S, Ippoliti C _et al_. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. _Br J Haematol_
2005; 130: 409–417. Article CAS Google Scholar * Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E _et al_. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem
cell transplantation. _Biol Blood Marrow Transplant_ 2005; 11: 551–557. Article CAS Google Scholar * Fujino M, Kim Y, Ito M . Intestinal thrombotic microangiopathy induced by FK506 in
rats. _Bone Marrow Transplant_ 2007; 39: 367–372. Article CAS Google Scholar * Kummer M, Lev A, Reiter Y, Biedermann BC . Vascular endothelial cells have impaired capacity to present
immunodominant, antigenic peptides: a mechanism of cell type-specific immune escape. _J Immunol_ 2005; 174: 1947–1953. Article CAS Google Scholar * Ertault-Daneshpouy M, Leboeuf C, Lemann
M, Bouhidel F, Ades L, Gluckman E _et al_. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. _Blood_ 2004; 103: 4681–4684. Article CAS Google
Scholar * Sieg A, Hachmoeller-Eisenbach U, Eisenbach T . Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. _Gastrointest Endosc_
2001; 53: 620–627. Article CAS Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Hematology, Japanese Red Cross Nagoya First Hospital,
Nagoya, Japan Y Inamoto, T Nishida, S Nishiwaki, T Oba, Y Kodera & K Miyamura * Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Y
Inamoto, T Nishida, M Murata, M Yanada & T Naoe * Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan M Ito, M Fujino & N Hirabayashi * Department of
HSCT Data Management, Nagoya University School of Medicine, Nagoya, Japan R Suzuki * Department of Hematology, Meitetsu Hospital, Nagoya, Japan H Iida * Department of Hematology and
Oncology, Konan Kosei Hospital, Konan, Japan A Kohno & Y Morishita * Department of Hematology, Anjo Kosei Hospital, Anjo, Japan M Sawa * Department of Pathology, Nagoya University
Graduate School of Medicine, Nagoya, Japan R Ichihashi * Department of Gastroenterology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan T Yamaguchi Authors * Y Inamoto View author
publications You can also search for this author inPubMed Google Scholar * M Ito View author publications You can also search for this author inPubMed Google Scholar * R Suzuki View author
publications You can also search for this author inPubMed Google Scholar * T Nishida View author publications You can also search for this author inPubMed Google Scholar * H Iida View author
publications You can also search for this author inPubMed Google Scholar * A Kohno View author publications You can also search for this author inPubMed Google Scholar * M Sawa View author
publications You can also search for this author inPubMed Google Scholar * M Murata View author publications You can also search for this author inPubMed Google Scholar * S Nishiwaki View
author publications You can also search for this author inPubMed Google Scholar * T Oba View author publications You can also search for this author inPubMed Google Scholar * M Yanada View
author publications You can also search for this author inPubMed Google Scholar * T Naoe View author publications You can also search for this author inPubMed Google Scholar * R Ichihashi
View author publications You can also search for this author inPubMed Google Scholar * M Fujino View author publications You can also search for this author inPubMed Google Scholar * T
Yamaguchi View author publications You can also search for this author inPubMed Google Scholar * Y Morishita View author publications You can also search for this author inPubMed Google
Scholar * N Hirabayashi View author publications You can also search for this author inPubMed Google Scholar * Y Kodera View author publications You can also search for this author inPubMed
Google Scholar * K Miyamura View author publications You can also search for this author inPubMed Google Scholar CONSORTIA FOR THE NAGOYA BLOOD AND MARROW TRANSPLANTATION GROUP CORRESPONDING
AUTHOR Correspondence to Y Inamoto. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Inamoto, Y., Ito, M., Suzuki, R. _et al._ Clinicopathological
manifestations and treatment of intestinal transplant-associated microangiopathy. _Bone Marrow Transplant_ 44, 43–49 (2009). https://doi.org/10.1038/bmt.2008.419 Download citation *
Received: 01 July 2008 * Revised: 17 November 2008 * Accepted: 21 November 2008 * Published: 12 January 2009 * Issue Date: July 2009 * DOI: https://doi.org/10.1038/bmt.2008.419 SHARE THIS
ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * allogeneic transplantation * microangiopathy * intestinal * GVHD * pathology